These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 407823)

  • 1. Effect of aerosol immunization with RE 595 Salmonella minnesota on lung bactericidal activity against Serratia marcescens, Enterobacter cloacae, and Pseudomonas aeruginosa.
    LaForce FM
    Am Rev Respir Dis; 1977 Aug; 116(2):241-9. PubMed ID: 407823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heightened lung bactericidal activity in mice after aerosol immunization with Re 595 Salmonella minnesota: importance of cellular rather than humoral factors.
    LaForce FM; Boose DS; Mills DM
    J Infect Dis; 1980 Sep; 142(3):421-31. PubMed ID: 7003033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional role of antibody against "core" glycolipid of Enterobacteriaceae.
    Young LS; Stevens P; Ingram J
    J Clin Invest; 1975 Oct; 56(4):850-61. PubMed ID: 1099119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune stimulation of lung bactericidal activity: evidence for both cellular and humoral participation after immunization with Serratia marcescens.
    LaForce FM; Boose D
    Am Rev Respir Dis; 1980 Jun; 121(6):921-9. PubMed ID: 6998336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing the immune enhancement of intrapulmonary bactericidal mechanisms.
    Jakab GJ
    Infect Immun; 1976 Aug; 14(2):389-98. PubMed ID: 9364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific and Nonspecific immunity to Serratia marcescens infection.
    Simberkoff MS; Moldover NH; Rahal JJ
    J Infect Dis; 1976 Oct; 134(4):348-53. PubMed ID: 789788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards serodiagnosis of Serratia marcescens infections: examination of sera from noninfected patients and from experimentally infected rabbits for anti-H and anti-O antibodies; S. marcescens O-antigen cross-reactions with those of other enterobacteriaceae.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):490-6. PubMed ID: 7036590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific pulmonary defences against Pseudomonas aeruginosa after local immunization with temperature-sensitive mutants.
    Sordelli DO; Cerquetti MC; Bellanti JA; Morris Hooke A
    J Gen Microbiol; 1987 Oct; 133(10):2835-41. PubMed ID: 3130459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The virulence of Enterobacter cloacae and Serratia marcescens in experimental bladder infection in diabetic mice.
    Obana Y; Nishino T
    J Med Microbiol; 1989 Oct; 30(2):105-9. PubMed ID: 2677380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral vaccination against Porteus mirabilis.
    Jones RJ
    Br J Exp Pathol; 1976 Aug; 57(4):395-9. PubMed ID: 822863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross protective immunity in mice injected with heat-killed cells of Pseudomonas aeruginosa and Serratia marcescens.
    Homma JY; Ito M; Yabuuchi E
    Jpn J Exp Med; 1972 Dec; 42(6):583-5. PubMed ID: 4634197
    [No Abstract]   [Full Text] [Related]  

  • 12. Mouse protection induced by Pseudomonas aeruginosa PAC1R and its defective mutants, Salmonella minnesota Re-mutant and Escherichia coli O14.
    Stanislavsky ES; Kholodkova EV; Makarenko TA; Sukhachevskaya MV
    FEMS Immunol Med Microbiol; 1995 Apr; 11(2):81-6. PubMed ID: 7640675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with R mutants of Salmonella minnesota. II. Comparison of the protective effect of immunization with lipid A and the Re mutant.
    Bruins SC; Stumacher R; Johns MA; McCabe WR
    Infect Immun; 1977 Jul; 17(1):16-20. PubMed ID: 407161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterobacter cloacae, Serratia marcescens and Yersinia enterocolitica in colonies of laboratory mice, rats and rabbits: an attempt of isolation.
    Shimoda K; Maejima K; Urano T
    Jikken Dobutsu; 1981 Oct; 30(4):503-5. PubMed ID: 7032956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxic immunity.
    Braude AI
    Adv Intern Med; 1980; 26():427-45. PubMed ID: 6784455
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune response to parental and rough mutant strains of Salmonella minnesota.
    Michael JG; Mallah I
    Infect Immun; 1981 Sep; 33(3):784-7. PubMed ID: 6793518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiologic study on the prevalence of Enterobacter, Serratia and Pseudomonas strains, producers of cefoxitin-inducible beta-lactamases].
    Marone P; Concia E; Perversi L; Cruciani M
    Boll Ist Sieroter Milan; 1986; 65(5):368-73. PubMed ID: 3103651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pseudomonas aeruginosa survival in the abdominal cavity of mice immunized with vaccines made from the Re mutant of Salmonella minnesota].
    Apollonin AV; Likhoded VG; Tabachnik AL; Kozlova NN
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Jul; (7):61-5. PubMed ID: 6812330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune enhancement of pulmonary bactericidal activity in murine virus pneumonia.
    Jakab GJ; Green GM
    J Clin Invest; 1973 Nov; 52(11):2878-84. PubMed ID: 4356001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precipitating antibody against core glycolipid of Enterobacteriaceae.
    Young LS; Stevens PR
    Experientia; 1974 Feb; 30(2):192-3. PubMed ID: 4205369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.